Stocks
Bluebird Bio (BLUE) EBITDA margin US GAAP (year values) |
|||||||||
| FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | LTM ? | CAGR 5 years ? | |||
| EBITDA margin, % | ? | -220.8% | -15 208% | -5 993% | -566.7% | -187.1% | -111.4% | ||
| Changes by years, y/y, % | +1 509pp | -14 987pp | +9 216pp | +5 426pp | +380pp | -35.9% | |||
Bluebird Bio. EBITDA margin, %
Bluebird Bio. EBITDA margin, changes, pp
Bluebird Bio (BLUE) EBITDA margin US GAAP (quarter values) |
||||||||
| FY2023Q4 | FY2024Q2 | FY2024Q3 | FY2024Q4 | FY2025Q1 | LTM ? | |||
| EBITDA margin, % | ? | -867.8% | -368.9% | -374.5% | -23.4% | -19.8% | -111.4% | |
| Changes by years, y/y, % | -43 918pp | +475pp | +340pp | +844pp | ||||
| Changes by quarters, q/q, % | -601pp | +499pp | -6pp | +351pp | +4pp | |||
